SCHEMBL23354501

SCHEMBL23354501

Cc1cc(C(=O)CNC(=O)OC(C)(C)C)n(C)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
TSHR P16473 2/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39
STING1 Q86WV6 7/20 0.39
CCNC P24863 1/20 0.39
CDK8 P49336 1/20 0.39
CACNA1H O95180 1/20 0.38
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
SIGMAR1 Q99720 1/20 0.37
GFER P55789 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPK14 Q16539 1/20 0.36
ACACB O00763 1/20 0.36
ACACA Q13085 1/20 0.36
DYRK1A Q13627 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23361711 0.81 ALDH1A1 (0.43) ALDH1A1MAPTCACNA1HKDM4ELMNA
SCHEMBL25322343 0.81 PCSK9 (0.40) STING1CACNA1HKDM4ELMNAMEN1
SCHEMBL25322333 0.81 PCSK9 (0.40) STING1CACNA1HKDM4ELMNAMEN1
SCHEMBL23384726 0.77 KMT2A (0.46) ALDH1A1TSHRKDM4ELMNASIGMAR1
SCHEMBL27815924 0.76 ALDH1A1 (0.42) ALDH1A1MAPTCDK8CACNA1HKDM4E
SCHEMBL23371309 0.74 GAA (0.41) ALDH1A1TSHRCCNCCDK8KDM4E
SCHEMBL23371337 0.74 KDM4E (0.39) ALDH1A1KDM4ELMNASIGMAR1GFER
SCHEMBL35210874 0.74 SMN1; SMN2 (0.57) CCNCCDK8KDM4ESMN1; SMN2MAPK14
SCHEMBL12307407 0.74 STING1 (0.44) ALDH1A1STING1CCNCCDK8GFER
SCHEMBL23371306 0.73 KDM4E (0.38) ALDH1A1TSHRMAPTHPGDCCNC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists BAYER AKTIENGESELLSCHAFT (DE) 2025-08-26 US disclosed
EP-4058448-B1 HYDANTOIN DERIVATIVES AS ADAMTS7 ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES BAYER AG (DE) 2024-05-29 EP disclosed
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2023-01-26 US disclosed
EP-4058448-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2022-09-21 EP disclosed
EP-3822268-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS Bayer Aktiengesellschaft (DE) 2021-05-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12398120-B2 Substituted hydantoinamides as ADAMTS7 antagonists ADAMTS7, MMP7, ADAM17 ALDH1A1 3828/4885TSHR 1345/4885MAPT 4828/4885
US-20230027346-A1 SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS ADAMTS7, MMP7, ADAM17 ALDH1A1 3828/4885TSHR 1345/4885MAPT 4828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.